Increasing substance P levels in serum and synovial tissues from patients with developmental dysplasia of the hip (DDH)

BMC Musculoskeletal Disorders

Xiao-Dong Chen¹  Yi-Min Cui¹  Jun-Feng Zhu¹  Chao Shen¹  Zheng Li¹  Xiang Zhang¹  Xin-Feng Zheng¹  Hui Wang¹ 

[1]Department of Orthopaedic Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Kongjiang Road, No.1665, Yangpu District, Shanghai, China

关键词: Osteoarthritis;    Chronic pain;    NK-1 receptor;    Synovium;    DDH;    Substance P;   

Others  :  1127831
DOI  :  10.1186/1471-2474-15-92

 received in 2013-09-29, accepted in 2014-03-10,  发布年份 2014

【 摘 要 】

Background

The tachykininergic neurotransmitters have been proved to be involved in the inflammatory progress and chronic pain in series of disease. The present study was undertaken to evaluate the levels of substance P (SP) and its receptors NK-1 receptor (NK-1R) in both serum and synovial tissues of hip joint from patients with different stages of DDH, and to detect the possible correlation of serum SP levels with pain sensation and dysfunction of the hip joint.

Methods

SP levels in serum and synovial tissues from patients with DDH and DDH combined with osteoarthritis (DDH&OA) group were compared through immunohistochemistry (IHC), ELISA, and 2-step acetic acid extraction method respectively. Expression of NK-1R in synovial tissues was compared through IHC, quantitive Real-Time PCR (QRT-PCR) and Western-Blot. The severities of pain sensation and the functional activities of hip joint were assessed by Visual analogue scale (VAS) and Harris hip score (HHS). Correlations of serum SP levels with VAS, HHS and erythrocyte sedimentation rate (ESR) were evaluated respectively in these groups.

Results

Significantly elevated serum SP levels were detected in group of DDH and DDH&OA compared to that in normal group. IHC, QRT-PCR as well as tissue Elisa showed that SP levels in synovial tissue of DDH&OA group is stronger than that in DDH group. Serum SP levels in each group have no gender differences. The enhanced SP levels in synovial tissue mainly came from the segregation of peripheral nerve endings. Serum SP correlated with VAS and HHS in patients with DDH&OA (Male + Female). Serum SP correlated with HHS in patients with DDH (Male). Serum SP levels also correlated with erythrocyte sedimentation rate (ESR) in patients with DDH&OA (Male + Female). Up-regulated expression of NK-1R was also observed in synovial tissue of patients with DDH&OA compared to patients with DDH, through western-blot, IHC, and QRT-PCR.

Conclusions

These findings indicated that the increasing SP levels in serum and synovial tissues, observed from patients with DDH to patients with DDH&OA, might associate with the loss of function and chronic pain sensation in hip joint. SP along with its receptors NK-1R might be involved in the progression of DDH into DDH&OA. In the future, inhibitors of SP as well as NK-1R may represent a novel pharmacotherapy target for pain relieving, inflammation alleviating and joint degeneration delaying for patients with DDH.

【 授权许可】

   
2014 Wang et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Lisle R, Boekelaar M, Stannage K, Whitewood C: Delayed diagnosis of developmental dislocation of the hip: the Western Australian experience. ANZ J Surgery 2012, 82:612-615.
• [2]Shi D, Dai J, Zhu P, Qin J, Zhu L, Zhu H, Zhao B, Qiu X, Xu Z, Chen D, Yi L, Ikegawa S, Jiang Q: Association of the D repeat polymorphism in the ASPN gene with developmental dysplasia of the hip: a case–control study in Han Chinese. Arthritis Res Ther 2011, 13:R27. BioMed Central Full Text
• [3]Bo N, Peng W, Xinghong P, Ma R: Early cartilage degeneration in a rat experimental model of developmental dysplasia of the hip. Connect Tissue Res 2012, 53:513-520.
• [4]Ortiz-Neira CL, Paolucci EO, Donnon T: A meta-analysis of common risk factors associated with the diagnosis of developmental dysplasia of the hip in newborns. Eur J Radiol 2012, 81:e344-351.
• [5]de Hundt M, Vlemmix F, Bais JM, Hutton EK, de Groot CJ, Mol BW, Kok M: Risk factors for developmental dysplasia of the hip: a meta-analysis. Eur J Obstet Gynecol Reprod Biol 2012, 165:8-17.
• [6]Shi D, Dai J, Ikegawa S, Jiang Q: Genetic study on developmental dysplasia of the hip. Eur J Clin Invest 2012, 42:1121-1125.
• [7]Hogervorst T, Eilander W, Fikkers JT, Meulenbelt I: Hip ontogenesis: how evolution, genes, and load history shape hip morphotype and cartilotype. Clin Orthop Relat Res 2012, 470:3284-3296.
• [8]Stelzeneder D, Mamisch TC, Kress I, Domayer SE, Werlen S, Bixby SD, Millis MB, Kim YJ: Patterns of joint damage seen on MRI in early hip osteoarthritis due to structural hip deformities. Osteoarthritis Cartilage 2012, 20:661-669.
• [9]Nakamura J, Oinuma K, Ohtori S, Watanabe A, Shigemura T, Sasho T, Saito M, Suzuki M, Takahashi K, Kishida S: Distribution of hip pain in osteoarthritis patients secondary to developmental dysplasia of the hip. Mod Rheumatol 2013, 23:119-124.
• [10]Hung SP, Sheu MJ, Ma MC, Hu JT, Sun YY, Lee CC, Chung YC, Tsai YJ, Wang JY, Chen CL: Runx1-deficient afferents impair visceral nociception, exacerbating dextran sodium sulfate-induced colitis. Brain Behav Immun 2013, 1591(13):00457-1.
• [11]Mitchell AJ, Lone AM, Tinoco AD, Saghatelian A: Proteolysis controls endogenous substance P levels. PLos One 2013, 8:e68638.
• [12]Ahmed AS, Li J, Erlandsson-Harris H, Stark A, Bakalkin G, Ahmed M: Suppression of pain and joint destruction by inhibition of the proteasome system in experimental osteoarthritis. Pain 2012, 153:18-26.
• [13]Uematsu T, Sakai A, Ito H, Suzuki H: Intra-articular administration of tachykinin NK-1 receptor antagonists reduces hyperalgesia and cartilage destruction in the inflammatory joint in rats with adjuvant-induced arthritis. Eur J Pharmacol 2011, 668:163-168.
• [14]Ferland CE, Laverty S, Beaudry F, Vachon P: Gait analysis and pain response of two rodent models of osteoarthritis. Pharmacol Biochem Behav 2011, 97:603-610.
• [15]Ferland CE, Beaudry F, Vachon P: Antinociceptive effects of eugenol evaluated in a monoiodoacetate-induced osteoarthritis rat model. Phytother Res 2012, 26:1278-1285.
• [16]Ahmed AS, Li J, Ahmed M, Hua L, Yakovleva T, Ossipov MH, Bakalkin G, Stark A: Attenuation of pain and inflammation in adjuvant-induced arthritis by the proteasome inhibitor MG132. Arthritis Rheum 2010, 62:2160-2169.
• [17]Liu D, Jiang LS, Dai LY: Substance P and its receptors in bone metabolism. Neuropeptide 2007, 41:271-283.
• [18]Hartig-Andreasen C, Søballe K, Troelsen A: The role of the acetabular labrum in hip dysplasia. Acta Orthop 2013, 84:60-64.
• [19]Terjesen T, Gunderson RB: Radiographic evaluation of osteoarthritis of the hip: an inter-observer study of 61 hips treated for late-detected developmental hip dislocation. Acta Orthop 2012, 83:185-189.
• [20]Kellgren JH, Lawrence JS: Radiological assessment of osteoarthrosis. Ann Rheum Dis 1957, 16:494-502.
• [21]Nakamura S, Ninomiya S, Nakamura T: Primary osteoarthritis of the hip joint in Japan. Clin Orthop Relat Res 1989, 241:190-196.
• [22]Cashman JP, Round J, Taylor G, Clarke NM: The natural history of developmental dysplasia of the hip after early supervised treatment in the Pavlik harness. A prospective, longitudinal follow-up. J Bone Joint Surg Br 2002, 84:418-425.
• [23]Zhu J, Chen X, Cui Y, Shen C, Cai G: Mid-term results of Bernese periacetabular osteotomy for developmental dysplasia of hip in middle aged patients. Int Orthop 2013, 37:589-594.
• [24]Albers CE, Steppacher SD, Ganz R, Tannast M, Siebenrock KA: Impingement Adversely Affects 10-year Survivorship After Periacetabular Osteotomy for DDH. Clin Orthop Relat Res 2013, 471:1602-1614.
• [25]Öztürk N, Erin N, Tüzüner S: Changes in tissue substance P levels in patients with carpal tunnel syndrome. Neurosurgery 2010, 67:1655-1660.
• [26]Yamada M, Ogata M, Kawai M, Mashima Y, Nishida T: Substance P and its metabolites in normal human tears. Invest Ophthalmol Vis Sci 2002, 43:2622-2625.
• [27]Erin N, Ulusoy O: Differentiation of neuronal from non-neuronal substance P. Regul Pept 2009, 152:108-113.
• [28]Erin N, Ersoy Y, Ercan F, Akici A, Oktay S: NK-1 antagonist CP99994 inhibits stress-induced mast cell degranulation in rats. Clin Exp D ermatol 2004, 29:644-648.
• [29]Santangelo KS, Bertone AL: Effective reduction of the interleukin-1β transcript in osteoarthritis-prone guinea pig chondrocytes via short hairpin RNA mediated RNA interference influences gene expression of mediators implicated in disease pathogenesis. Osteoarthritis Cartilage 2011, 19:1449-1457.
• [30]Wu X, Li SH, Lou LM, Cai ZD: The techniques of soft tissue release and true socket reconstruction in total hip arthroplasty for patients with severe developmental dysplasia of the hip. Int Orthop 2012, 36:1795-1801.
• [31]Al-Moussa S, Moroz P, Beaulé PE: Effect of pelvic osteotomy in the skeletally immature on acetabular coverage. HSS J 2012, 8:235-239.
• [32]Li J, Kreicbergs A, Bergstrom J, Stark A, Ahmed M: Site-specific CGRP innervation coincides with bone formation during fracture healing and modeling: a study in rat angulated tibia. J Orthop Res 2007, 25:1204-1212.
• [33]Ogbonna AC, Clark AK, Gentry C, Hobbs C, Malcangio M: Pain-like behaviour and spinal changes in the monosodium iodoacetate model of osteoarthritis in C57Bl/6 mice. Eur J Pain 2013, 4:514-526.
• [34]Zhang RX, Ren K, Dubner R: Osteoarthritis pain mechanisms: basic studies in animal models. Osteoarthritis Cartilage 2013, 9:1308-1315.
• [35]Grimsholm O, Rantapää-Dahlqvist S, Forsgren S: Levels of gastrin-releasing peptide and substance P in synovial fluid and serum correlate with levels of cytokines in rheumatoid arthritis. Arthritis Res Ther 2005, 7:R416-R426. BioMed Central Full Text
• [36]Carvalho B, Clark DJ, Angst MS: Local and systemic release of cytokines, nerve growth factor, prostaglandin E2, and substance P in incisional wounds and serum following cesarean delivery. J Pain 2008, 9:650-657.
• [37]O’ Shaughnessy MC, Vetsika EK, Inglis JJ, Carleson J, Haigh R, Kidd BL, Winyard PG: The effect of substance P on nitric oxide release in a rheumatoid arthritis model. Inflamm Res 2006, 55:236-240.
• [38]Lambert N, Lescoulié PL, Yassine-Diab B, Enault G, Mazières B, De Préval C, Cantagrel A: Substance P enhances cytokine-induced vascular cell adhesion molecule-1(VCAM-1) expression on cultured rheumatoid fibroblast-like synoviocytes. Clin Exp Immunol 1998, 113:269-275.
• [39]Cunin P, Caillon A, Corvaisier M, Garo E, Scotet M, Blanchard S, Delneste Y, Jeannin P: The tachykinins substance P and hemokinin-1 favor the generation of human memory Th17 cells by inducing IL-1β, IL-23, and TNF-like 1A expression by monocytes. J Immunol 2011, 186:4175-4182.
• [40]Schaible HG, Ebersberger A, Von Banchet GS: Mechanisms of pain in arthritis. Ann N Y Acad Sci 2002, 966:343-354.
• [41]Muto Y, Sakai A, Sakamoto A, Suzuki H: Activation of NK1 receptors in the locus coeruleus induces analgesia through noradrenergic-mediated descending inhibition in a rat model of neuropathic pain. Br J Pharmacol 2012, 166:1047-1057.
• [42]Lee SE, Kim JH: Involvement of substance P and calcitonin gene-related peptide in development and maintenance of neuropathic pain from spinal nerve injury model of rat. Neurosci Res 2007, 58:245-249.
• [43]Jang JH, Nam TS, Paik KS, Leem JW: Involvement of peripherally released substance P and calcitonin gene-related peptide in mediating mechanical hyperalgesia in a traumatic neuropathy model of the rat. Neurosci Lett 2004, 360:129-132.
• [44]Makino A, Sakai A, Ito H, Suzuki H: Involvement of tachykinins and NK1 receptor in the joint inflammation with collagen type II-specific monoclonal antibody-induced arthritis in mice. J Nippon Med Sch 2012, 79:129-38.
• [45]Luccarini P, Henry M, Alvarez P, Gaydier AM, Dallel R: Contribution of neurokinin 1 receptors in the cutaneous orofacial inflammatory pain. Naunyn Schmiedebergs Arch Pharmacol 2003, 368:320-323.
• [46]Saito T, Koshino T: Nerve distribution in synovium of osteoarthritic knees. Clin Calcium 2002, 12:59-62.
• [47]Tesarz J, Hoheisel U, Wiedenhöfer B, Mense S: Sensory innervation of the thoracolumbar fascia in rats and humans. Neuroscience 2011, 194:302-308.
• [48]Saito T, Koshino T: Distribution of neuropeptides in synovium of the knee with osteoarthritis. Clin Orthop Relat Res 2000, 376:172-182.
• [49]Vilensky JA, O’Connor BL, Fortin JD, Merkel GJ, Jimenez AM, Scofield BA, Kleiner JB: Histologic analysis of neural elements in the human sacroiliac joint. Spine 2002, 27:1202-1207.
• [50]Engman J, Åhs F, Furmark T, Linnman C, Pissiota A, Appel L, Frans Ö, Langström B, Fredrikson M: Age, sex and NK1 receptors in the human brain – a positron emission tomography study with [11C]GR205171. Eur Neuropsychopharmacol 2012, 22:562-568.
• [51]Yamazaki M, Sato I: Distribution of substance P and the calcitonin gene-related peptide in the human tensor tympani muscle. Eur Arch Otorhinolaryngol 2013. Epub ahead of print